| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.9M | +634.2% |
| R&D Expense | $25.0M | -49.6% |
| SG&A Expense | $13.1M | -52.3% |
| Operating Income | -$35.1M | +54.7% |
| Interest Expense | $3.2M | +165.3% |
| Net Income | -$37.7M | +52.1% |
| EPS (Basic) | -$0.17 | +54.1% |
| EPS (Diluted) | -$0.17 | +54.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.1M | -48.6% |
| Accounts Receivable | $4K | -99.6% |
| Current Assets | $53.8M | -31.8% |
| Total Assets | $64.9M | -31.5% |
| Current Liabilities | $24.2M | +50.7% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $26.4M | -28.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.2M | +52.4% |
| Capital Expenditures | $216K | -93.5% |
| Investing Cash Flow | -$193K | +94.2% |
| Financing Cash Flow | $6.4M | -75.3% |
| Free Cash Flow | -$29.4M | +54.5% |
| Stockholders' Equity |
| $38.6M |
| -33.6% |